Reuters -- Europe’s economic jitters will clean out the health-science industry, leaving global generic as well as innovative drugmakers among the survivors, the head of Swiss drugmaker Roche (ROG.VX) predicted on Wednesday.
Reuters -- Europe’s economic jitters will clean out the health-science industry, leaving global generic as well as innovative drugmakers among the survivors, the head of Swiss drugmaker Roche (ROG.VX) predicted on Wednesday.
